Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both? Source: Eur Respir J 2015; 46: 1551-1553 Year: 2015
The investigation of malignancy in unprovoked pulmonary embolism (PE): An audit of practice at a district general hospital Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013
Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014
Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art Source: Eur Respir Rev 2009; 19: 55-58 Year: 2010
Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016
Pulmonary embolism in China: disease burden, management and prevention Source: Virtual Congress 2020 – Chinese programme 2020: Part II Year: 2020
Prognostic role of excessive exercise ventilation in non-operable patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease Year: 2016
Improving identification and early referral of pulmonary hypertension patients Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016
Analysis of importance of clinical and laboratory parameters for clinical course and outcome of septic or no septic pulmonary embolism Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013
The value of revised Geneva scoring system and D-dimer evaluation in the patients with suspicion of pulmonary embolism, admitted to the department of lung diseases Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015
Is there a role for risk stratification for ambulatory management of Pulmonary Embolism? Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017
Factors influencing mortality in ICU patients with suspected massive pulmonary embolism Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016
Do we ever learn? Risk stratification and investigation of suspected pulmonary embolism Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013
Pulmonary embolism and the consequences for the right heart Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136 Year: 2006
Chronic obstructive pulmonary disease surveillance: Potential usefulness of the Texas behavioral risk factor survey surveillance system Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012
Chronic thromboembolic disease following pulmonary embolism: more work ahead Source: Eur Respir J, 55 (4) 2000229; 10.1183/13993003.00229-2020 Year: 2020
Prognostic role of respiratory failure in acute pulmonary embolism:a pulmonologist’s point of view Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018